Erik Helmerhorst
- Physiology top 5%
- Alzheimer's disease research and treatments 6
- Neurology top 5%
- Endocrine and Autonomic Systems top 10%
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 4
-
- Metabolism, Diabetes, and Cancer 8
- Glycosylation and Glycoproteins Research 4
- Protein Interaction Studies and Fluorescence Analysis 4
- Protein Structure and Dynamics 3
-
- Natural Antidiabetic Agents Studies 5
-
- Pancreatic function and diabetes 5
- Co-authors
- G. B. StokesRalph N. MartinsKevin TaddeiWilhelm van BronswijkLing XieCyril MamotteDavid ChandlerRicardo L. Mancera
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Erik Helmerhorst
33 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 117
- Physiology 599
- Neurology 149
- Cellular and Molecular Neuroscience 223
- Endocrine and Autonomic Systems 82
- Clinical Biochemistry 76
Countries citing papers authored by Erik Helmerhorst
This map shows the geographic impact of Erik Helmerhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Helmerhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Helmerhorst more than expected).
Fields of papers citing papers by Erik Helmerhorst
This network shows the impact of papers produced by Erik Helmerhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Helmerhorst. The network helps show where Erik Helmerhorst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik Helmerhorst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 8 | |
| 4 | 2020 | 17 | |
| 5 | 2019 | 4 | |
| 6 | 2016 | 12 | |
| 7 | 2016 | 8 | |
| 8 | 2013 | 24 | |
| 9 | 2008 | 46 | |
| 10 | 2006 | 14 | |
| 11 | 2004 | 3 | |
| 12 | 2004 | 0 | |
| 13 | Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. | 2002 | 436 |
| 14 | Decreased secretion of amyloid precursor protein in Chinese hamster ovary cells overexpressing presenilin 1 | 1999 | 2 |
| 15 | 1999 | 40 | |
| 16 | 1993 | 1 | |
| 17 | 1992 | 2 | |
| 18 | 1986 | 14 | |
| 19 | 1986 | 15 | |
| 20 | 1983 | 20 |
About Erik Helmerhorst
Erik Helmerhorst is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Molecular Biology, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (8 papers), Alzheimer's disease research and treatments (6 papers), Natural Antidiabetic Agents Studies (5 papers), Pancreatic function and diabetes (5 papers), Glycosylation and Glycoproteins Research (4 papers), Advanced Glycation End Products research (4 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers) and Protein Structure and Dynamics (3 papers). The work is most often cited by research in Physiology (599 citations), Neurology (149 citations) and Cellular and Molecular Neuroscience (223 citations). Erik Helmerhorst has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include G. B. Stokes, Ralph N. Martins, Kevin Taddei, Wilhelm van Bronswijk, Ling Xie, Cyril Mamotte, David Chandler, Ricardo L. Mancera, Suzanne Craft and Pablo Vinuesa. Their work appears in journals such as Journal of Neuroscience, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.